11 September 2020 - Deborah Wilkes
Archived
Australia’s Therapeutic Goods Administration (TGA) is set to allow low-dose cannabidiol (CBD) medicines to be sold without a prescription.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.